Old Topics

Governments play a critical role in setting standards, regulations, and providing the necessary infrastructure for a robust cold chain. Their contributions include: Regulations and Standards: Governments ensure that cold chain operations comply with health and safety standards. This is particularly important in sectors like pharmaceuticals, where temperature control is essential for efficacy, and food, where

Industry is at the heart of the cold chain community, providing the infrastructure, technology, and practical expertise needed to operate cold chains efficiently. The role of industry includes: Infrastructure Development: Industry players build and manage the physical infrastructure of cold chains, such as refrigerated warehouses, vehicles, and storage facilities. These stakeholders ensure that the necessary

Academia brings cutting-edge research, deep knowledge, and educational programs to the cold chain ecosystem. Research and Technological Innovation: Universities and research institutions conduct studies on cold chain systems, exploring areas like new refrigeration technologies, packaging innovations, temperature-monitoring systems, and energy-efficient solutions. Their research can lead to breakthroughs that make cold chains more cost-effective, reliable, and

Union Minister of Housing & Urban Affairs, Manohar Lal Khattar on Tuesday said that India will be soon be holding an experiment regarding standardisation of AC temperatures, restricting air conditioners from cooling below 20°C or heating beyond 28°C. This comes amid India’s Meteorological Department (IMD) issuing orange alert over a heatwave in Delhi and residents reeling under

Mumbai: After operating with just five food safety officers (FSOs) for nearly a year. the city’s food and Drug Administration (FDA) is expected to appoint at least 40 new FSOs by June 7, in a bid to address a severs staffing shortfall.

The Central Drugs Standard Control Organization (CDSCO) has established a new unit — the “Coordination Division” — as India broadens the mandate of its drug regulatory authority beyond just quality testing, News18 has learnt. The division is responsible for several functions, ranging from preparing monthly reports for the Cabinet to managing special assignments from senior

DHL Group already has an established  Life Sciences and Healthcare  business, contributing over EUR 5 billion in global revenue in 2024. Building on this foundation, the acquisition of CRYOPDP marks a significant step in  DHL‘s commitment to enhancing its capabilities in specialized pharma logistics and expanding the breadth of its offering in the rapidly growing

Vaccine maker Bharat Biotech International Ltd (BBIL) has set up India’s only vertically integrated, purpose-designed Cell & Gene Therapy (C&GT) Infrastructure & Viral Vector Production facility in Genome Valley here with an investment of $75 million.  “With this, we are moving beyond vaccine innovation to leading-edge regenerative and personalised therapies that promise hope for millions,’‘ Krishan